en.aazsante.fr

The Largest Portal Of Health And Quality Of Life.

First immuno-cancer to treat lung cancer approved in Brazil

First immuno-cancer to treat lung cancer approved in Brazil

National Surveillance Agency (ANVISA) approved the registration of Opdivo (nivolumabe), the global biopharmaceutical company Bristol? Myers Squibb. The drug is now authorized by the agency to treat two of the most aggressive types of the disease according to INCA: locally advanced or metastatic lung cancer and metastatic melanoma.

The nivolumabe is the first immuno-oncology available in Brazil for patients with lung cancer and the most innovative therapy to emerge in the last ten years to combat this type of disease. The drug offers the possibility of reaching up to double the survival compared to the treatment currently available in the market. With Opdivo (nivolumabe), Bristol presents significant data never before verified for lung cancer and, through the pioneering of its researches in immuno-oncology, has come to the forefront of the treatment of advanced and metastatic melanoma in the country. developing innovative treatment options aimed at providing long-term survival for cancer patients. "9 The approval of nivolumab in the Brazilian market represents one of the major contributions to the oncology armamentarium against lung cancer and melanoma. with metastatic melanoma as patients with metastatic lung cancer have a better option than chemotherapy and yet with fewer side effects, "says the chief of the Oncology Center Antonio Ermírio de Morais, Hospital São José, linked to Beneficência Portuguesa, Dr. For the president of Bristol in Brazil, Caetano Crupi, nivolumabe represe the first stage of the immuno-oncology that will allow to face the cancer with a perspective of potential of control of the disease. "Immunotherapy represents a new standard in the care of patients with this very serious disease."

Opdivo (nivolumabe) approval for lung cancer and melanoma fulfills the promise of delivery of immuno-oncology in challenging states of disease and Bristol will continue to lead this science in the new areas that have unmet medical needs.

The drug is expected to be available for commercialization later this year once the pricing definition is completed by the Market Regulation Chamber

Cancer data

According to the National Cancer Institute (INCA), in Brazil, there are 28,190 new cases of lung cancer expected between 2016 and 2017, of which 17,330 are men and 10,860 in women. A study conducted by the American Cancer Society in partnership with the International Agency for Research on Cancer (IARC) points out that lung cancer is the leading cause of death among men and women in developed countries.

According to the Organization World Health Organization (WHO), the incidence of melanoma has been increasing in the last four decades. In 2012 there were more than 232,000 new cases around the world and the outlook is that in 2015 this number has risen to 250,178 new cases. In Brazil, the disease accounts for only 4% of malignant neoplasms in the country and estimates of new cases for 2016 and 2017 are 5,670, 3,000 for men and 2,670 for women.

Still according to the WHO, the the cancer epidemic will reach 22 million people around the world by 2030.


Back pain may be a sign of stenosis

Back pain may be a sign of stenosis

The World Health Organization and the United Nations have declared the years 2000 to 2010 to be a decade dedicated to improving the quality of life for people with musculoskeletal disorders around the world. Second estimates of the American Association (AANS) and the Congress of Neurosurgeons (CNS), about 400,000 Americans over 60 suffer from symptoms of lumbar canal stenosis.

(Health)

Panic syndrome has treatment, but diagnosis is difficult

Panic syndrome has treatment, but diagnosis is difficult

The fear that new crises occur produces different types of phobia, manifested by a process of association, after the first crisis, reacting to any internal stimuli (pain, dizziness, palpitations , etc.) or external (full place, tunnel, closed environment such as bus, subway, etc.) that can trigger a new irrational crisis of illogical fear, with sudden crises of anguish and fear that provoke a great physical malaise.

(Health)